Published Paper Details:

The gynecologic disorder known as adenomyosis is heterogeneous. Adenomyosis patients may present with a variety of clinical symptoms. Although patients with adenomyosis can occasionally present asymptomatic, excessive menstrual bleeding and dysmenorrhea are the most prevalent presentations. There are currently no accepted diagnostic imaging standards, making it difficult to determine which course of action is best for each patient. Diagnosing adenomyosis and assessing its response to treatment can be difficult because women with this condition frequently have other related gynecologic conditions, such as endometriosis or leiomyomas. This study aimed to present the most recent clinical data concerning the adenomyosis pathophysiology, imaging findings, clinical symptoms, diagnosis, risk factors, and treatment. The idea that adenomyosis arises from endometrial invasion of the myometrium, resulting in changes to the junctional zone, is supported by a number of studies. Imaging tests including magnetic resonance imaging (MRI) and transvaginal ultrasound (TVUS) frequently reveal these alterations. The second most popular explanation holds that pluripotent mullerian fragments that are displaced during embryonic development cause adenomyosis. Historically, adenomyosis was only identified after a hysterectomy; however, research has indicated that biopsies obtained during laparoscopy and hysteroscopy can also identify the condition. A differential diagnosis can be guided by noninvasive imaging. A review is conducted on the most prevalent findings on 2-dimensional/3-dimensional TVUS and MRI. Though new research suggests that 3-dimensional TVUS is preferable to 2-dimensional TVUS for the diagnosis of adenomyosis and may enable the detection of early-stage disease, both two-dimensional TVUS and MRI have reasonable sensitivity and specificity. Adenomyosis treatment options, including both surgical and medicinal ones, are discussed.